^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
BCMA CAR-T cell therapy
i
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Chongqing Precision Biotech
Drug class:
BCMA-targeted CAR-T immunotherapy
Related drugs:
Phase 1/2
Chongqing Precision Biotech Co., Ltd
Recruiting
Last update posted :
04/18/2023
Initiation :
12/01/2019
Primary completion :
12/31/2023
Completion :
07/01/2024
IL6
|
BCMA CAR-T cell therapy
Phase 1/2
Chongqing Precision Biotech Co., Ltd
Recruiting
Last update posted :
04/18/2023
Initiation :
03/07/2021
Primary completion :
12/31/2023
Completion :
07/01/2024
IL6
|
BCMA CAR-T cell therapy
Share
